AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 109 filers reported holding AXSOME THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $262,926 | -13.8% | 3,762 | -11.4% | 0.16% | -11.6% |
Q2 2023 | $305,189 | +28.2% | 4,247 | +10.0% | 0.18% | +38.2% |
Q1 2023 | $238,085 | -18.7% | 3,860 | +1.7% | 0.13% | -14.4% |
Q4 2022 | $292,708 | -37.1% | 3,795 | -63.6% | 0.15% | -17.3% |
Q3 2022 | $465,000 | +18.3% | 10,413 | +1.5% | 0.18% | +26.7% |
Q2 2022 | $393,000 | +88.0% | 10,259 | +103.0% | 0.15% | +55.3% |
Q1 2022 | $209,000 | +3.5% | 5,053 | -5.6% | 0.09% | +23.7% |
Q4 2021 | $202,000 | +94.2% | 5,350 | +70.1% | 0.08% | +65.2% |
Q3 2021 | $104,000 | -53.4% | 3,146 | -5.0% | 0.05% | -50.0% |
Q2 2021 | $223,000 | +4.7% | 3,313 | -11.8% | 0.09% | +2.2% |
Q1 2021 | $213,000 | -29.2% | 3,758 | +1.8% | 0.09% | -28.0% |
Q4 2020 | $301,000 | -1.0% | 3,690 | -13.6% | 0.12% | -21.4% |
Q3 2020 | $304,000 | -23.6% | 4,269 | -11.8% | 0.16% | -15.4% |
Q2 2020 | $398,000 | -11.9% | 4,839 | -37.1% | 0.19% | +1.1% |
Q1 2020 | $452,000 | -50.3% | 7,688 | -12.6% | 0.19% | +24.8% |
Q4 2019 | $910,000 | +306.2% | 8,801 | -20.5% | 0.15% | +231.1% |
Q3 2019 | $224,000 | -25.6% | 11,076 | -5.3% | 0.04% | -28.6% |
Q2 2019 | $301,000 | – | 11,692 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 785,683 | $60,599,730 | 58.10% |
Fairmount Funds Management LLC | 2,011,647 | $155,158,333 | 24.61% |
VR Adviser, LLC | 670,718 | $51,732,479 | 8.72% |
Ghost Tree Capital, LLC | 235,000 | $18,126,000 | 7.74% |
SVB FINANCIAL GROUP | 33,849 | $2,610,773 | 7.14% |
Tri Locum Partners LP | 200,054 | $15,430,000 | 6.24% |
BVF INC/IL | 1,755,000 | $135,363,150 | 5.71% |
RTW INVESTMENTS, LP | 2,980,482 | $229,884,577 | 4.69% |
TANG CAPITAL MANAGEMENT LLC | 320,000 | $24,681,600 | 3.59% |
PFM Health Sciences, LP | 1,092,831 | $84,290,055 | 3.02% |